A M ROSS - JoVE Visualize

Showing results (91-100 of 101) with videos related to

Pageof 11

Sort By:

Journal of the American College of Cardiology|November 13, 2001

A randomized, placebo-controlled trial of enoxaparin after high-risk coronary stenting: the ATLAST trialW B Batchelor, K W Mahaffey, P B Berger, et al.

Circulation|July 1, 1997

End-systolic volume index at 90 to 180 minutes into reperfusion therapy for acute myocardial infarction is a strong predictor of early and late mortality. The Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I Angiographic InvestigatorsR Q Migrino, J B Young, S G Ellis, et al.

Journal of the American College of Cardiology|October 1, 1992

Anistreplase versus alteplase in acute myocardial infarction: comparative effects on left ventricular function, morbidity and 1-day coronary artery patency. The TEAM-3 InvestigatorsJ L Anderson, L C Becker, S G Sorensen, et al.

Circulation|November 15, 1996

Evolution of early TIMI 2 flow after thrombolysis for acute myocardial infarction. GUSTO-1 Angiographic InvestigatorsJ S Reiner, C F Lundergan, A Fung, et al.

Journal of the American College of Cardiology|December 1, 1996

Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experienceS L Woodfield, C F Lundergan, J S Reiner, et al.

Journal of the American College of Cardiology|December 10, 1999

A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial. PACT investigators. Plasminogen-activator Angioplasty Compatibility TrialA M Ross, K S Coyne, J S Reiner, et al.

Circulation|March 7, 1998

Non-Q-wave versus Q-wave myocardial infarction after thrombolytic therapy: angiographic and prognostic insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries-I angiographic substudy. GUSTO-I Angiographic InvestigatorsS G Goodman, A Langer, A M Ross, et al.

American Heart Journal|June 30, 2001

Predictors of left ventricular function after acute myocardial infarction: effects of time to treatment, patency, and body mass index: the GUSTO-I angiographic experienceC F Lundergan, A M Ross, W F McCarthy, et al.

Circulation|May 21, 1998

Extended mortality benefit of early postinfarction reperfusion. GUSTO-I Angiographic Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries TrialA M Ross, K S Coyne, E Moreyra, et al.

Circulation|October 15, 1996

Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trialH D White, G I Barbash, R M Califf, et al.

Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:

Pageof 11

Journal of the American College of Cardiology|November 13, 2001

A randomized, placebo-controlled trial of enoxaparin after high-risk coronary stenting: the ATLAST trialW B Batchelor, K W Mahaffey, P B Berger, et al.

Circulation|July 1, 1997

End-systolic volume index at 90 to 180 minutes into reperfusion therapy for acute myocardial infarction is a strong predictor of early and late mortality. The Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I Angiographic InvestigatorsR Q Migrino, J B Young, S G Ellis, et al.

Journal of the American College of Cardiology|October 1, 1992

Anistreplase versus alteplase in acute myocardial infarction: comparative effects on left ventricular function, morbidity and 1-day coronary artery patency. The TEAM-3 InvestigatorsJ L Anderson, L C Becker, S G Sorensen, et al.

Circulation|November 15, 1996

Evolution of early TIMI 2 flow after thrombolysis for acute myocardial infarction. GUSTO-1 Angiographic InvestigatorsJ S Reiner, C F Lundergan, A Fung, et al.

Journal of the American College of Cardiology|December 1, 1996

Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experienceS L Woodfield, C F Lundergan, J S Reiner, et al.

Journal of the American College of Cardiology|December 10, 1999

A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial. PACT investigators. Plasminogen-activator Angioplasty Compatibility TrialA M Ross, K S Coyne, J S Reiner, et al.

Circulation|March 7, 1998

Non-Q-wave versus Q-wave myocardial infarction after thrombolytic therapy: angiographic and prognostic insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries-I angiographic substudy. GUSTO-I Angiographic InvestigatorsS G Goodman, A Langer, A M Ross, et al.

American Heart Journal|June 30, 2001

Predictors of left ventricular function after acute myocardial infarction: effects of time to treatment, patency, and body mass index: the GUSTO-I angiographic experienceC F Lundergan, A M Ross, W F McCarthy, et al.

Circulation|May 21, 1998

Extended mortality benefit of early postinfarction reperfusion. GUSTO-I Angiographic Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries TrialA M Ross, K S Coyne, E Moreyra, et al.

Circulation|October 15, 1996

Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trialH D White, G I Barbash, R M Califf, et al.

Pageof 11